Fibrogen Inc CS (FGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FGEN | GLYC | RLMD | ||
| Company | Fibrogen Inc CS | Glycomimetics Inc | Relmada Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.1200 | 1.8000 | 3.62 | ||
| High | 1.2168 | 1.9300 | 3.83 | ||
| Low | 1.0900 | 1.6200 | 3.62 | ||
| Last | 1.1700 | 1.6200 | 3.69 | ||
| Change | +0.0500 | -0.1800 | +0.05 | ||
| % Change | +4.46% | -10.00% | +1.37% | ||
| Volume | 1,088,800 | 980,500 | 64,000 | ||
| 20-Day Average Volume | 1,352,585 | 849,480 | 119,685 | ||
| Previous Close | 1.1200 | 1.8000 | 3.64 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.2632 | 2.1332 | 4.24 | ||
| 20-Day Raw Stochastic | 29.42% | 8.15% | 19.54% | ||
| 20-Day Relative Strength | 39.95% | 34.43% | 38.39% | ||
| Weighted Alpha | -79.04 | -24.38 | -12.21 | ||
| Today's Opinion | 24% Sell | 40% Sell | 24% Sell | ||
| Previous Opinion | 24% Sell | 40% Sell | 24% Sell | ||
| Last Month's Opinion | 72% Buy | 64% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.87% since 04/24/24 | -12.67% since 04/24/24 | -4.40% since 04/24/24 | ||
| Low | 0.9011 on 04/25/24 | 1.5100 on 04/30/24 | 3.35 on 04/29/24 | ||
| High | 1.2168 on 05/01/24 | 1.9300 on 05/01/24 | 3.97 on 04/29/24 | ||
| 1-Month | |||||
| %Chg | -50.42% since 04/01/24 | -46.71% since 04/01/24 | -24.39% since 04/01/24 | ||
| Low | 0.9011 on 04/25/24 | 1.5100 on 04/30/24 | 3.35 on 04/29/24 | ||
| High | 2.3300 on 04/02/24 | 3.1600 on 04/02/24 | 5.09 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | -50.63% since 02/01/24 | -44.71% since 02/01/24 | -19.08% since 02/01/24 | ||
| Low | 0.9011 on 04/25/24 | 1.5100 on 04/30/24 | 3.35 on 04/29/24 | ||
| High | 2.9300 on 02/12/24 | 3.3800 on 02/12/24 | 7.22 on 03/04/24 | ||
| 6-Month | |||||
| %Chg | +113.85% since 11/01/23 | +28.57% since 11/01/23 | +23.83% since 11/01/23 | ||
| Low | 0.3333 on 11/10/23 | 1.1700 on 11/09/23 | 2.41 on 12/01/23 | ||
| High | 2.9300 on 02/12/24 | 3.5299 on 01/23/24 | 7.22 on 03/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 111,411 | 116,010 | 109,833 | ||
| Shares Outstanding, K | 99,474 | 64,450 | 30,174 | ||
| Annual Sales | 147,750,000 | 10,000 | 0 | ||
| Annual Net Income | -284,230,000 | -36,900,000 | -98,790,000 | ||
| Last Quarter Sales | 27,140,000 | 10,000 | 0 | ||
| Last Quarter Net Income | -56,230,000 | -9,080,000 | -25,170,000 | ||
| 60-Month Beta | 0.70 | 2.18 | 0.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.57 on 02/26/24 | -0.14 on 03/27/24 | -0.84 on 03/19/24 | ||
| Latest Earnings Date | 05/06/24 | 05/09/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||